Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. (Q39908136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

Erratum: Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

18 January 2020

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/ONC.2009.1

author

Vincenzo Calvanese

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Manel Esteller

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Antonello Mai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lucia Altucci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Pilar López Nieva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

Maria Luz Martinez Chantar

18 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dante Rotili

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Angela Nebbioso

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Julen Oyarzabal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Manuel Serrano

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

E Lara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Varela-Rey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Ropero

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G Montoya

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Velasco

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Witt

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Villar-Garea

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Imhof

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J M Mato

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M F Fraga

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

8 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

781-791

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2008.436

18 January 2020

exact match

0 references

cites work

Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Identification of a small molecule inhibitor of Sir2p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

21 January 2018

2D structure depiction.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Structure of the histone deacetylase SIRT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Cross-talk between aging and cancer: the epigenetic language

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Epigenetics and aging: the targets and the marks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Histone deacetylases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Calorie restriction--the SIR2 connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Development and validation of a genetic algorithm for flexible docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Sirtuins in aging and age-related disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Negative control of p53 by Sir2alpha promotes cell survival under stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

HDACs and HDAC inhibitors in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Discovery and development of SAHA as an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Crystal structure of a SIR2 homolog-NAD complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Exploring protein native states and large-scale conformational changes with a modified generalized born model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Top-down proteomics on a chromatographic time scale using linear ion trap fourier transform hybrid mass spectrometers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

p53 mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Trastuzumab plus tamoxifen: anti-proliferative and molecular interactions in breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Function of the SIRT1 protein deacetylase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Comparative and pharmacophore model for deacetylase SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

SirT1 fails to affect p53-mediated biological functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Force fields for protein simulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

Analysis of histone modifications by mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.436

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19060927%20AND%20SRC:MED&resulttype=core&format=json

release_uxby6nk2jvbbvpy4lbyybkbnk4

18 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uxby6nk2jvbbvpy4lbyybkbnk4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference